Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication

Surgical Endoscopy

Volumn 27, Issue 8, 2013, Pages 2940-2946

  Frazzoni, Marzio ^a   Piccoli, Micaela ^a   Conigliaro, Rita ^a   Manta, Raffaele ^a   Frazzoni, Leonardo ^a   Melotti, Gianluigi ^a  

^a Nuovo Ospedale S Agostino   (Italy)

Author keywords

Antireflux surgery; Impedance pH monitoring; Laparoscopic fundoplication; Nonacid reflux; Refractory GERD; Robotic fundoplication; Weakly acidic reflux

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DIGESTIVE SYSTEM EXAMINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; IMPEDANCE PH MONITORING; LAPAROSCOPIC SURGERY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REMISSION; ROBOTICS; STOMACH FUNDOPLICATION; SURGICAL EQUIPMENT; SYMPTOM; TREATMENT DURATION;

ADULT; ESOPHAGEAL PH MONITORING; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; LAPAROSCOPY; MALE; MANOMETRY; MIDDLE AGED; RETROSPECTIVE STUDIES; ROBOTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881374895     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-013-2861-3     Document Type: Article

References (32)

1. Kahrilas PJ, Shaheen NJ, Vaezi MF (2008) American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 135:1392-1413
2. Sifrim D, Zerbib F (2012) Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut 61:1340-1354
3. Dallemagne B, Weerts J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, Jehaes C (2006) Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc 20:159-165
4. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson DS, Fanelli RD; The SAGES Guidelines Committee (2010) Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24:2647-2669
5. Tutuian R, Castell DO (2006) Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance. Aliment Pharmacol Ther 24(Suppl 2):27-37
6. Pandolfino JE, Vela MF (2009) Esophageal reflux monitoring. Gastrointest Endosc 69:917-930
7. Frazzoni M, Conigliaro R, Melotti G (2011) Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy. A study using impedance-pH monitoring. Dig Dis Sci 56:1099-1106
8. Frazzoni M, Conigliaro R, Colli G, Melotti G (2012) Conventional versus robot-assisted laparoscopic Nissen fundoplication. A comparison of postoperative acid reflux parameters. Surg Endosc 26:1675-1681
9. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GNJ, Wallin L (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45:172-180
10. Frazzoni M, Conigliaro R, Mirante VG, Melotti G (2012) The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil 24:141-e87
11. Frazzoni M, Grisendi A, Lanzani A, Melotti G, De Micheli E (2002) Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease - a pH-metric comparison. Dig Liver Dis 34:99-104
12. Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, Bertani H, Manta R, Conigliaro R (2009) Reflux patterns in patients with short segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther 30:508-515
13. Sifrim D, Castell D, Dent J, Kahrilas PJ (2004) Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53:1024-1031
14. Zerbib F, Roman S, Ropert A, Bruley des Varannes S, Pouderoux P, Chaput U, Mion F, Verin E, Galmiche JP, Sifrim D (2006) Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 101:1956-1963
15. Agrawal A, Roberts J, Sharma N, Tutuian R, Vela M, Castell DO (2009) Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus 22:467-470
16. Fass R (2012) Therapeutic options for refractory gastroesophageal reflux disease. J Gastroenterol Hepatol 27(Suppl 3):3-7
17. Frazzoni M, Conigliaro R, Manta R, Melotti G (2011) Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther 34:67-75
18. Witteman B, Strijkers R, de Vries E, Toemen L, Conchillo JM, Hameetemn W, Dagnelie PC, Koek GH, Bouvy ND (2012) Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc 26:3307-3315
19. Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Langstrom G, Lind T, Lundell L (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD - the LOTUS randomized clinical trial. JAMA 305:1969-1977
20. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO (2006) Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 93:1483-1487
21. Broeders JA, Rijnhart-de Jong HG, Draaisma WA, Bredenoord AJ, Smout AJ, Gooszen HG (2009) Ten-year outcome of laparoscopic and conventional Nissen fundoplication: randomized clinical trial. Ann Surg 250:698-706
22. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900-1920
23. Bytzer P (2004) Assessment of reflux symptom severity: methodological options and their attributes. Gut 53(Suppl 4):iv28-iv34
24. Slaughter JC, Goutte M, Rymer JA, Oranu AC, Schneider JA, Garrett CG, Hagaman D, Vaezi MF (2011) Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 9:868-874
25. Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF (2009) Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 7:743-748
26. Frazzoni M, Conigliaro R, Melotti G (2011) Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis. Aliment Pharmacol Ther 33:601-606
27. Krishnan K, Pandolfino J, Kahrilas P, Keffer L, Boris L, Komandur S (2012) Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology 143:576-581
28. Bredenoord AJ, Draaisma WA, Weusten BLAM, Gooszen HG, Smout AJPM (2008) Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut 57:161-166
29. Herbella F, Vicentine F, Del Grande J, Patti MG (2011) Postprandial proximal gastric acid pocket in patients after laparoscopic Nissen fundoplication. Surg Endosc 25:3198-3201
30. Benson K, Hartz A (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878-1886
31. Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887-1892
32. Scarpignato C (2012) Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end! Neurogastroenterol Motil 24:697-704